Login / Register The Most Trusted Name in Medical Education

Pulmonology

Elsevier's CME pulmonary activities are geared for pulmonologists, respiratory specialists, primary care physicians, and other healthcare clinicians responsible for the care of patients with respiratory issues.

116x140 AZ Spec SNAP

Focusing on Patients With Severe Asthma: From Guideline Recommendations to Daily Clinical Decision-Making

Format: Webcast Series

Welcome to this Severe Asthma CME Snapshot ™ video series. Each 15-minute module offers focused, clinically actionable education for pulmonologists, clinical immunologists, and other clinicians who manage patients with severe asthma. For a comprehensive curriculum that provides a practical set of recommendations to improve daily functioning and quality of life among patients with severe asthma, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit ™. 

Take Course »

Credits: 0.25 AMA PRA Category 1 Credit™ per module
Banner 116x141

Evolving SMA Treatment Landscape

Format: Resource Center

Welcome to Progress in Spinal Muscular Atrophy (SMA) Management, an Elsevier Learning Center. This learning center is a freely accessible platform that aims to increase clinical knowledge by providing Continuing Medical Education (CME) activities, research articles, and resources for health care professionals (HCPs) who treat patients with spinal muscular atrophy (SMA).

Take Course »

Credits: 0.50 AMA PRA Category 1 Credit™ and 0.50 Nursing Contact Hour
116x141

ADVANCING THE CARE OF SEVERE ASTHMA: Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Format: Webcast Series

Welcome to this Severe Asthma CME Snapshot ™ video series. Each 15-minute module offers focused, clinically actionable education for primary care providers and other clinicians who manage patients with severe asthma. For a comprehensive curriculum that provides a practical set of recommendations on improving daily functioning and quality of life among patients with severe asthma, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit ™.

Take Course »

Credits: 0.25 AMA PRA Category 1 Credit™ per module
910799 116 x 140

ATS 2018: An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive Pulmonary Disease (COPD)

Format: Conference Reporter

The American Thoracic Society (ATS) International Conference was held in San Diego, California, May 18-23, 2018. The ATS International Conference is the longest-running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on strategies in chronic obstructive pulmonary disease (COPD).

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference coverage educational programs.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Banner 3 Webcast dog ear 116x140

An Update on Emerging Therapies for Cystic Fibrosis and Their Implications for Clinical Outcomes: Independent CME Conference Highlights from the 2018 European Cystic Fibrosis Society (ECFS) Conference

Format: Webcast

With the rapid progress in the field of cystic fibrosis (CF), healthcare providers are continuously challenged to keep abreast of the latest data in the treatment and management of CF to achieve optimal care of people with CF. This activity provides analyses and clinical perspectives of new and emerging clinical trials data on CFTR modulators presented at the 2018 European Cystic Fibrosis Society (ECFS) Conference*. International expert faculty will examine these latest data, deliberate on the challenges associated with the evaluation of new agents, and discuss the implications of these data for people with CF.

*This webcast is not endorsed by the conference organizer. Elsevier Office of Continuing Medical Education is an independent medical education company that provides clinical updates, analysis, and expert perspectives through conference-coverage educational programs.

Take Course »

Credits: 1.5 AMA PRA Category 1 Credit™
910701 116 x 144

Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

Format: Webcast Series

This CME-accredited CME Snapshot™ educational series, Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care is intended for primary care clinicians and other health care providers involved in the ongoing management of patients with chronic obstructive pulmonary disease (COPD). Within each focused activity, an expert pulmonologist and a primary care educator discuss best practices for a specific aspect of managing patients with COPD, including monitoring the disease course over time, maximizing patient function, and individualizing treatment regimens. One activity also addresses patients’ perspectives by incorporating patient-clinician interactions and insights into disease burdens, challenges to good long-term outcomes, and shared decision-making. 

Take Course »

 

Credits: Up to 1.00 AMA PRA Category 1 Credit(s)™
910730 LC 116 x 140

Clinical Advances in Chronic Obstructive Pulmonary Disease: A Focus on Improving Patient Outcomes Learning Center

Format: Resource Center

Welcome to Clinical Advances in Chronic Obstructive Pulmonary Disease: A Focus on Improving Patient Outcomes Learning Center. The Learning Center provides you with free access to the latest clinical information relating to the diagnosis and management of COPD. The COPD Learning Center is a freely accessible platform that aims to increase clinical knowledge by providing continuing medical educational (CME) activities, research articles and resources for healthcare providers who treat patients with COPD.

Go to Learning Center »

910726 116 x 140

Aerosolized Agents for Airway Clearance in Cystic Fibrosis: When, How, Why? A Roundtable Discussion

Format: Webcast

This activity is presented as a roundtable discussion between three international expert faculty in cystic fibrosis (CF). This expert faculty will discuss the role of aerosolized agents for improving airway clearance, including caveats from their own extensive clinical experience in managing patients with this condition. The faculty will also deliberate on strategies to improve patient adherence to CF therapy in a case study based format. These discussions will support participants in clinical decision making as well as in helping their patients achieve optimal benefit through adherence to their CF therapy.

 

Take Course »

 

Credits: 1.50 AMA PRA Category 1 Credit(s)™
910729 116 x 140

CHEST 2017: AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN COPD

Format: Conference Reporter

The CHEST Annual Meeting 2017 was held in Toronto, Ontario, Canada, October 28–November 1, 2017. As the premier chest medicine education meeting for clinicians, CHEST unites leaders to discuss current pulmonary, critical care, and sleep medicine topics. In this activity, 2 experts summarize the key learnings from this year’s Annual Meeting, focusing on chronic obstructive pulmonary disease (COPD).

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit™
910742E 116 x 140

THE EMERGING ROLE OF CFTR COMBINATION REGIMENS IN IMPROVING OUTCOMES FOR PATIENTS WITH CYSTIC FIBROSIS

Format: Webcast

The content for this activity is based on the live, inter professional seminar titled, “The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis” that was presented at the 31st Annual North American Cystic Fibrosis Conference in Indianapolis, Indiana. This CME/CNE activity will highlight the latest advances in CFTR-based therapeutics for the treatment of patients with cystic fibrosis. The expert faculty will utilize an interactive panel format to present and discuss recent trial data as it relates to clinical decision-making, including updates regarding the assessment, monitoring, and management of patients treated with CFTR modulated therapies. This educational activity is intended to increase the knowledge and competencies of the multidisciplinary team involved in the care of the CF patient population. Upon completion of this educational activity, the healthcare team will be better equipped with vital information for improving outcomes and quality of life in patients with cystic fibrosis.

Take Course »

 

Credits: 1.50 AMA PRA Category 1 Credit(s)™ 1.50 Nursing Contact Hours
910694 116 x 140

Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis, Prognosis and Treatment

Format: Webcast

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrotic lung disease of unknown cause. Early diagnosis is a prerequisite for earlier treatment and, potentially, improved long-term clinical outcomes. Familiarity with novel treatment approaches that hold the promise of slowing disease progression and with the recent guideline recommendations is essential for all clinicians involved in the care of patients with IPF. Individualizing treatment is important in light of potential improved adherence to both drug therapy and health behaviors.

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
Elsevier Website Pleural Web 116x140 p2 thumbnail

Learning Center Progress in Pleural Mesothelioma

Format: Resource Center

Welcome to Progress in Pleural Mesothelioma, an Elsevier Learning Center. The aim of this learning center is to increase clinical knowledge by providing continuing medical education (CME) activities, research articles, and resources for health care professionals (HCPs) who treat patients with pleural mesothelioma.

Take Course »

Credits: 0.5 AMA PRA Category 1 Credit™
Banner 116x140

The 2017 Update of the Standard of Care Recommendations for Spinal Muscular Atrophy

Format: Webcast

This webcast is based on a discussion between two leading experts in the field of spinal muscular atrophy (SMA) who exchange views on “The 2017 Update of the Standard of Care Recommendations for SMA”.  They summarize and review the current best practices for diagnosis, multidisciplinary care, physical therapy, orthopedic care, nutrition, pulmonary care, and acute care and discuss how novel treatment options such as newly approved medications have impacted the outlook for patients and are changing the care setting. The experts provide an outlook on how developments such as newborn screening will influence the future of SMA management. 

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
910797 116 x 140

ATS 2018: An Update on Scientific Advances and Clinical Strategies in Interstitial Lung Disease (ILD)

Format: Conference Reporter

The American Thoracic Society (ATS) International Conference was held in San Diego, California, May 18-23, 2018. The ATS international conference is the longest running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on strategies in interstitial lung disease (ILD).

Take Course »

Credits: 1.0 AMA PRA Category 1 Credit™
116x140 ASTHMA AAAAI

Clinical Issues In Severe Asthma: Debates and Discussions About Personalizing Patient Management

Format: Webcast

During this web-based Clinical Issues™ program, a panel of expert faculty will discuss and debate a series of topics related to comprehensively evaluating and longitudinally managing patients with severe asthma, including how the evolving evidence base should shape clinical decision-making and implications of new study data presented at the 2018 American Thoracic Society International Conference.

Take Course »

Credits: 1.5 AMA PRA Category 1 Credit™
910647e 116 x 140

Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment

Format: Webcast

The content for this activity is based on the satellite symposium Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment that was presented on October 24, 2016 in Los Angeles, CA. Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrotic lung disease of unknown cause. Early diagnosis is a prerequisite for earlier treatment and, potentially, improved long-term clinical outcomes. Familiarity with novel treatment approaches that hold the promise of slowing disease progression and with the recent guideline recommendations is essential for all clinicians involved in the care of patients with IPF. Individualizing treatment is important in light of potential improved adherence to both drug therapy and health behaviors. 

Register »

 

Credits: 1.25 AMA PRA Category 1 Credit(s)™